Lascufloxacin-Induced QT Prolongation in an Elderly Patient Treated With Escitalopram: A Case Report
Abstract
Lascufloxacin is a novel fluoroquinolone antibacterial agent for respiratory infection in Japanese geriatrics. Although QT prolongation is a known adverse effect of fluoroquinolones, to our knowledge, QT prolongation associated with lascufloxacin has never been reported. Escitalopram is a selective serotonin reuptake inhibitor used to treat senile depression and can cause QT prolongation. Elderly patients are particularly susceptible to QT prolongation because polymorbidity and polypharmacy are common in geriatrics. In this report, we describe a case of severe QTc prolongation in an 89-year-old female patient who was administered lascufloxacin with escitalopram. Severe QTc prolongation was observed on the third day of lascufloxacin therapy, although escitalopram had already been used before the initiation of lascufloxacin. The QTc interval improved beyond the patient's baseline on the fourth day after lascufloxacin and escitalopram were changed to oral minocycline and paroxetine, respectively. Healthcare practitioners should be alert to the risk of severe QT prolongation when co-administering lascufloxacin and escitalopram because these drugs are frequently prescribed in Japanese geriatrics. Careful electrocardiogram (ECG) monitoring is recommended when lascufloxacin and escitalopram are co-administered, particularly in elderly patients. Similar to this case, polypharmacy and medication safety are critical issues that should be addressed in Japanese geriatrics.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.